Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
Date:5/5/2009

to support further clinical development of this formulation.
  • Strategic Focus of Cash Resources
    • In March, Poniard announced that it would concentrate its cash resources on the clinical and commercial development of picoplatin. As a result, on March 31, 2009, the Company discontinued its in-house preclinical research operations and reduced its workforce by approximately 12 percent, or eight employees. The Company continues to evaluate strategic alternatives for its preclinical research programs and related assets.

  • First Quarter 2009 Unaudited Financial Results

    The Company reported a net loss of $13.0 million ($0.38 diluted loss per share on a loss applicable to common shares of $13.1 million) for the quarter ended March 31, 2009 compared with a net loss of $9.9 million ($0.29 diluted loss per share on a loss applicable to common shares of $10.0 million) for the quarter ended March 31, 2008.

    Total operating expenses for the quarter ended March 31, 2009, were $12.2 million compared with $10.5 million for the quarter ended March 31, 2008. Total operating expenses for the first quarter of 2009 include a charge of $1.1 million for the restructuring and related asset impairment resulting from the Company's strategic restructuring plan to discontinue its in-house preclinical research operations and reduce its workforce by approximately 12 percent effective March 31, 2009.

    Research and development expenses were $8.1 million for the quarter ended March 31, 2009, compared with $6.3 million for the quarter ended March 31, 2008.

    General and administrative expenses were $3.1 million for the quarter ended March 31, 2009, compared with $4.2 million for the quarter ended March 31, 2008.

    Cash and investment securities as of March 31, 2009
    '/>"/>

    SOURCE Poniard Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
    2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
    3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
    4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
    5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
    6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
    7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
    8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
    9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
    10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
    11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... and LONDON , December 24, 2014 ... are expected to grow at an average rate of ... value and volume. Hip, knee and spine surgeries are ... in emerging economies they have a lower penetration. Increased ... the use of composites. Non-metallic orthopedic devices have gained ...
    (Date:12/24/2014)... December 24, 2014 ... Global Disposable Syringe Industry of 178 pages ... business intelligence library. The 2014 ... Industry is a professional and deep research ... overview analysis, the report introduces Disposable Syringe ...
    (Date:12/24/2014)... Dec. 23, 2014 Tianyin Pharmaceutical Co., ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today announced that the Company achieved the Public ... Practice (GMP) certificate of TPI,s Qionglai Facility (QLF) ... The public notice period is a significant procedure ...
    Breaking Medicine Technology:Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
    ... -- The,following is a transcript of remarks by President ... Room , 2:39 P.M. EDT , THE PRESIDENT: Welcome. ... the world in science and technology. Our,innovative spirit is ... and cure diseases. America is also a,nation founded on ...
    ... VASTox plc (AIM: VOX), a leading,UK biotechnology company, ... £400,000 by the Welsh Development Agency,(”WDA”) under the ... months, will support the research and development,work undertaken ... unique skills and expertise of its scientists,based there. ...
    Cached Medicine Technology:Remarks by President Bush on Stem Cell Veto and Executive Order 2Remarks by President Bush on Stem Cell Veto and Executive Order 3Remarks by President Bush on Stem Cell Veto and Executive Order 4Remarks by President Bush on Stem Cell Veto and Executive Order 5Remarks by President Bush on Stem Cell Veto and Executive Order 6Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3
    (Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
    (Date:12/25/2014)... has updated its blog to provide professional shopping tips on wedding ... at LunaDress.co.uk come with big discounts, up to 80 percent off. ... out to be a most exciting memory and can show off ... to a wedding. On the updated fashion blog, ladies can now ... big day . , Going out with friends to a party ...
    (Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- The risk ... the holidays, so you need to be extra cautious, ... Day, we see a significant increase in patients coming ... at the Suffolk County Volunteer Firefighters Burn Center of ... celebrations should be full of joy, but if not ...
    (Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
    (Date:12/25/2014)... AngelWeddingDress.com tries its best to translate ... Today, the business has introduced its new collection of ... promotion. , The new prom outfits are guaranteed to ... lover. They are specially designed for 2015. Anyone who ... should visit its website before Jan. 26, 2015, the ...
    Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
    ... , ATLANTA, Dec. 21 This winter, while many ... (NMA) is urging parents to also protect their families from ... Linda Fryer,s 16-year-old daughter Adrienne lost her life in less ... The killer was in fact meningococcal disease, which can lead ...
    ... The U.S. Senate this morning voted to move forward with ... to millions of Americans struggling with high costs and discriminatory ... guaranteed benefits that people in Medicare rely on, and make ... deny coverage to those who need it most. , AARP ...
    ... California ... ... are thinking about giving the gift of whiter teeth this holiday season, the California Dental ... shopper of this popular cosmetic process. , , ,“Tooth whitening is more popular than ever ...
    ... ... their fully revamped website, Surgery.org , ... New York, NY (Vocus) December 21, 2009 -- The American Society ... The new and improved web site has been overhauled with the preservation of core ...
    ... areas of concern , MONDAY, Dec. 21 (HealthDay News) -- ... ever before, with an increase seen in all age groups, including ... were recorded, a 1 percent increase from 2006, U.S. health officials ... births are up for the second year in a row, reversing ...
    ... , CANTON, Mass., Dec. 21 Organogenesis, Inc. ... (PMA) with the U.S. Food and Drug Administration (FDA) for ... regeneration. If approved, CelTx will be the first, living ... market. , A pioneer in the field, Organogenesis ...
    Cached Medicine News:Health News:Winter/Spring Brings Increased Meningitis Risk - Protect Preteens and Teens Now 2Health News:Winter/Spring Brings Increased Meningitis Risk - Protect Preteens and Teens Now 3Health News:AARP Maryland Applauds Senate for Moving Health Care Reform Forward 2Health News:AARP Maryland Applauds Senate for Moving Health Care Reform Forward 3Health News:Dreaming of a Whiter Christmas and New Year for Your Teeth? 2Health News:Surgery.org Gets a Facelift 2Health News:Surgery.org Gets a Facelift 3Health News:U.S. Births Reach Record High 2Health News:U.S. Births Reach Record High 3Health News:Organogenesis Files PMA for CelTx(TM) for Oral Soft Tissue Regeneration 2Health News:Organogenesis Files PMA for CelTx(TM) for Oral Soft Tissue Regeneration 3
    Great for small incisions and excision needs...
    Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
    2.5mm...
    ... with 12 bevel tip; silicone ... bevel is opposite curve, Designed ... fluid, Sleeve acts as stop ... minimize chance of trauma to ...
    Medicine Products: